View in EDS

Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.

Saved in:
Bibliographic Details
Title: Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Authors: Kim, E., Howes, O. D., Park, J. W., Kim, S. N., Shin, S. A, Kim, B.-H., Turkheimer, F. E., Lee, Y.-S., Kwon, J. S.
Source: Psychological Medicine. Jan2016, Vol. 46 Issue 2, p357-366. 10p.
Subjects: Blood testing, Body weight, Statistical correlation, Liquid chromatography, Classification of mental disorders, Obsessive-compulsive disorder, Research funding, Statistical sampling, Serotonin, Statistics, Stature, T-test (Statistics), Positron emission tomography, Data analysis, Randomized controlled trials, Severity of illness index, Data analysis software, Descriptive statistics, Citalopram, Therapeutics
Geographic Terms: South Korea
Abstract: Background. Obsessive-compulsive disorder (OCD) is a chronic, relapsing mental illness. Selective serotonin reuptake inhibitors block serotonin transporters (SERTs) and are the mainstay of treatment for OCD. SERT abnormalities are reported in drug-free patients with OCD, but it is not known what happens to SERT levels during treatment. This is important as alterations in SERT levels in patients under treatment could underlie poor response, or relapse during or after treatment. The aim of the present study was first to validate a novel approach to measuring SERT levels in people taking treatment and then to investigate SERT binding potential (BP) using [11C]DASB PET in patients with OCD currently treated with escitalopram in comparison with healthy controls. Method. Twelve patients and age- and sex-matched healthy controls were enrolled. The patients and healthy controls underwent serial PET scans after administration of escitalopram and blood samples for drug concentrations were collected simultaneously with the scans. Drug-free BPs were obtained by using an inhibitory Emax model we developed previously. Results. The inhibitory Emax model was able to accurately predict drug-free SERT BP in people taking drug treatment. The drug-free BP in patients with OCD currently treated with escitalopram was significantly different from those in healthy volunteers [Cohen's d = 0.03 (caudate), 1.16 (putamen), 1.46 (thalamus), -5.67 (dorsal raphe nucleus)]. Conclusions. This result extends previous findings showing SERT abnormalities in drug-free patients with OCD by indicating that altered SERT availability is seen in OCD despite treatment. This could account for poor response and the high risk of relapse in OCD. [ABSTRACT FROM AUTHOR]
Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 111830542
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [<superscript>11</superscript>C]DASB PET study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kim%2C+E%2E%22">Kim, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Howes%2C+O%2E+D%2E%22">Howes, O. D.</searchLink><br /><searchLink fieldCode="AR" term="%22Park%2C+J%2E+W%2E%22">Park, J. W.</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+S%2E+N%2E%22">Kim, S. N.</searchLink><br /><searchLink fieldCode="AR" term="%22Shin%2C+S%2E+A%22">Shin, S. A</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+B%2E-H%2E%22">Kim, B.-H.</searchLink><br /><searchLink fieldCode="AR" term="%22Turkheimer%2C+F%2E+E%2E%22">Turkheimer, F. E.</searchLink><br /><searchLink fieldCode="AR" term="%22Lee%2C+Y%2E-S%2E%22">Lee, Y.-S.</searchLink><br /><searchLink fieldCode="AR" term="%22Kwon%2C+J%2E+S%2E%22">Kwon, J. S.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psychological+Medicine%22">Psychological Medicine</searchLink>. Jan2016, Vol. 46 Issue 2, p357-366. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Blood+testing%22">Blood testing</searchLink><br /><searchLink fieldCode="DE" term="%22Body+weight%22">Body weight</searchLink><br /><searchLink fieldCode="DE" term="%22Statistical+correlation%22">Statistical correlation</searchLink><br /><searchLink fieldCode="DE" term="%22Liquid+chromatography%22">Liquid chromatography</searchLink><br /><searchLink fieldCode="DE" term="%22Classification+of+mental+disorders%22">Classification of mental disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Obsessive-compulsive+disorder%22">Obsessive-compulsive disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Statistical+sampling%22">Statistical sampling</searchLink><br /><searchLink fieldCode="DE" term="%22Serotonin%22">Serotonin</searchLink><br /><searchLink fieldCode="DE" term="%22Statistics%22">Statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Stature%22">Stature</searchLink><br /><searchLink fieldCode="DE" term="%22T-test+%28Statistics%29%22">T-test (Statistics)</searchLink><br /><searchLink fieldCode="DE" term="%22Positron+emission+tomography%22">Positron emission tomography</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis%22">Data analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Severity+of+illness+index%22">Severity of illness index</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis+software%22">Data analysis software</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Citalopram%22">Citalopram</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22South+Korea%22">South Korea</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background. Obsessive-compulsive disorder (OCD) is a chronic, relapsing mental illness. Selective serotonin reuptake inhibitors block serotonin transporters (SERTs) and are the mainstay of treatment for OCD. SERT abnormalities are reported in drug-free patients with OCD, but it is not known what happens to SERT levels during treatment. This is important as alterations in SERT levels in patients under treatment could underlie poor response, or relapse during or after treatment. The aim of the present study was first to validate a novel approach to measuring SERT levels in people taking treatment and then to investigate SERT binding potential (BP) using [11C]DASB PET in patients with OCD currently treated with escitalopram in comparison with healthy controls. Method. Twelve patients and age- and sex-matched healthy controls were enrolled. The patients and healthy controls underwent serial PET scans after administration of escitalopram and blood samples for drug concentrations were collected simultaneously with the scans. Drug-free BPs were obtained by using an inhibitory Emax model we developed previously. Results. The inhibitory Emax model was able to accurately predict drug-free SERT BP in people taking drug treatment. The drug-free BP in patients with OCD currently treated with escitalopram was significantly different from those in healthy volunteers [Cohen's d = 0.03 (caudate), 1.16 (putamen), 1.46 (thalamus), -5.67 (dorsal raphe nucleus)]. Conclusions. This result extends previous findings showing SERT abnormalities in drug-free patients with OCD by indicating that altered SERT availability is seen in OCD despite treatment. This could account for poor response and the high risk of relapse in OCD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=111830542
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1017/S0033291715001865
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 357
    Subjects:
      – SubjectFull: Blood testing
        Type: general
      – SubjectFull: Body weight
        Type: general
      – SubjectFull: Statistical correlation
        Type: general
      – SubjectFull: Liquid chromatography
        Type: general
      – SubjectFull: Classification of mental disorders
        Type: general
      – SubjectFull: Obsessive-compulsive disorder
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Statistical sampling
        Type: general
      – SubjectFull: Serotonin
        Type: general
      – SubjectFull: Statistics
        Type: general
      – SubjectFull: Stature
        Type: general
      – SubjectFull: T-test (Statistics)
        Type: general
      – SubjectFull: Positron emission tomography
        Type: general
      – SubjectFull: Data analysis
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Severity of illness index
        Type: general
      – SubjectFull: Data analysis software
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Citalopram
        Type: general
      – SubjectFull: Therapeutics
        Type: general
      – SubjectFull: South Korea
        Type: general
    Titles:
      – TitleFull: Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim, E.
      – PersonEntity:
          Name:
            NameFull: Howes, O. D.
      – PersonEntity:
          Name:
            NameFull: Park, J. W.
      – PersonEntity:
          Name:
            NameFull: Kim, S. N.
      – PersonEntity:
          Name:
            NameFull: Shin, S. A
      – PersonEntity:
          Name:
            NameFull: Kim, B.-H.
      – PersonEntity:
          Name:
            NameFull: Turkheimer, F. E.
      – PersonEntity:
          Name:
            NameFull: Lee, Y.-S.
      – PersonEntity:
          Name:
            NameFull: Kwon, J. S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 01
              Text: Jan2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 00332917
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Psychological Medicine
              Type: main
ResultId 1